Literature DB >> 9100978

Proteasomes and antigen processing.

K Tanaka1, N Tanahashi, C Tsurumi, K Y Yokota, N Shimbara.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9100978     DOI： 10.1016/s0065-2776(08)60885-8

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  20 in total

1.  gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation.

Authors:  S Bose; P Brooks; G G Mason; A J Rivett
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

Authors:  P Brooks; G Fuertes; R Z Murray; S Bose; E Knecht; M C Rechsteiner; K B Hendil; K Tanaka; J Dyson; J Rivett
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Association of immunoproteasomes with the endoplasmic reticulum.

Authors:  P Brooks; R Z Murray; G G Mason; K B Hendil; A J Rivett
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.

Authors:  Edwin R Manuel; William A Charini; Pritha Sen; Fred W Peyerl; Marcelo J Kuroda; Jörn E Schmitz; Patrick Autissier; Dennis A Sheeter; Bruce E Torbett; Norman L Letvin
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.

Authors:  J Li; X Gao; J Ortega; T Nazif; L Joss; M Bogyo; A C Steven; M Rechsteiner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

Review 6.  Therapeutic cancer vaccines: the latest advancement in targeted therapy.

Authors:  Marijo Bilusic; Ravi A Madan
Journal:  Am J Ther       Date:  2012-11       Impact factor: 2.688

7.  Identification of an activation region in the proteasome activator REGalpha.

Authors:  Z Zhang; A Clawson; C Realini; C C Jensen; J R Knowlton; C P Hill; M Rechsteiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 8.  Immunotherapy in prostate cancer: emerging strategies against a formidable foe.

Authors:  Marijo Bilusic; Christopher Heery; Ravi A Madan
Journal:  Vaccine       Date:  2011-07-07       Impact factor: 3.641

9.  Rpn9 is required for efficient assembly of the yeast 26S proteasome.

Authors:  J Takeuchi; M Fujimuro; H Yokosawa; K Tanaka; A Toh-e
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

10.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Authors:  K B Hendil; S Khan; K Tanaka
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.